FDA Commissioner Marty Makary leaves post after about 13 months in office
The Facts
- Marty Makary left his position as commissioner of the Food and Drug Administration on May 12.
- Makary had served as FDA commissioner for a little over a year, with several reports describing his tenure as about 13 months.
- President Donald Trump publicly said Makary was leaving and described him to reporters as a "terrific guy."
- Multiple reports said Makary's departure followed pressure and disputes over FDA policy, including criticism tied to flavored vape approvals and to abortion-pill policy.
- Kyle Diamantas, an FDA deputy commissioner, is expected to lead the agency in an acting capacity after Makary's departure.
- Makary's exit is part of broader turnover in the federal health leadership under the Trump administration and HHS Secretary Robert F. Kennedy Jr.
- The leadership change matters because the FDA oversees regulation of drugs, medical devices, food safety and related health products, and the agency is now operating under interim leadership while a permanent successor is chosen.
- It remains unresolved whether Makary resigned entirely on his own or was effectively pushed out, as reports described both a resignation and prior White House approval of a plan to remove him.
How left and right are reading this
- Both agree
- An agency with sweeping authority over drugs, devices, food safety and other health products is now under interim leadership after a contested departure, and neither framing treats that kind of uncertainty at the FDA as trivial.
- They split on
- Less a disagreement than a question of emphasis: the risk that broader health-leadership churn weakens steady public-health oversight, versus the need for a clear, disciplined account of whether the commissioner resigned or was effectively pushed out.
Analytical frames for this storyTap to explore
Context
Who is running the FDA now?
Reports say Kyle Diamantas, an FDA deputy commissioner, will serve as acting commissioner following Makary's departure Medscape,Guardian,Fox News.
View all 100 sources
Wire services (7)
Independent coverage (50)
Anadolu AjansıTrump says Marty Makary is out as Food and Drug Administrati...
AxiosMakary's exit creates new uncertainty at FDA
infobaeTrump destituyó al titular de la Administración de Alimentos...
Diario EL PAIS UruguayEnfrentado con el presidente y presionado por la Casa Blanca...
FirstpostTrump's FDA chief is out after angering pharma CEOs, vaping ...
ExcélsiorRenuncia el jefe de la FDA tras meses de presión política y ...
RT en EspañolRenuncia el jefe de la Administración de Alimentos y Medicam...
The Wall Street JournalInside Marty Makary's Downfall at the FDA
BreitbartFDA Commissioner Marty Makary Resigns Amid Reports of Firing
Raw StoryDr. Marty Makary resigns from Trump's FDA
Le Monde.frLe patron de l'Agence américaine du médicament quitte son po...
Deseret NewsFDA chief resigns: Here is what we know
El ObservadorCambio en salud de EEUU: renuncia el jefe de la FDA bajo el ...
El Nuevo DíaRenuncia el jefe de la FDA: estas fueron las razones
El Comercio PerúRenuncia el jefe de la agencia de medicamentos y seguridad a...
La Nación, Grupo NaciónRenuncia el jefe de la agencia de medicamentos y seguridad a...
TIMEFDA Commissioner Marty Makary Resigns
VoxFlavored vapes doomed Trump's FDA head
The Boston GlobeMakary's exit from FDA gives biotech hope 'circus' is over -...
The HillFDA Commissioner Marty Makary resigns
Caracol RadioRenunció el jefe de la agencia de medicamentos y seguridad a...
Khaleej timesTrump announces departure of FDA's Makary; Kyle Diamantas to...
Men's HealthExclusive: Marty Makary's Final Interview as FDA Commissione...
Ars TechnicaFDA chief resigns after Trump admin forced approval of fruit...
GEO TVFDA Commissioner Marty Makary out after vape policy clashes
Le DevoirLe chef de l'Agence américaine du médicament démissionne, an...
Hindustan TimesWhy did Marty Makary resign as FDA chief? Clash over flavore...
CBC NewsMarty Makary exits FDA amid mounting complaints, including f...
STATWhy Marty Makary was the worst FDA commissioner in 25 years
Global NewsU.S. FDA head Marty Makary resigning after 13 months - Natio...
AolFDA Commissioner Marty Makary resigns after pressure campaig...
The HillTrump names acting FDA commissioner
Raw Story'Great job': Trump heaps praise on top official he pushed ou...
The Daily BeastTop FDA Official Pushed Out as MAGA Rift Rages
Prensa LibreRenuncia el director de la FDA
UnivisionMarty Makary deja la dirección de la FDA; Kyle Diamantas asu...
USA TodayFDA Commissioner Marty Makary resigns after pressure campaig...
mintWho is Kyle Diamantas? FDA food chief likely to lead agency ...
EL IMPARCIAL | Noticias de México y el mundoSiguen las salidas en la administración de Trump: Ahora el c...
RedstateDr. Marty Makary Exits the FDA Amidst Conflicts With MAHA an...
EL PAÍSEl jefe de la agencia del medicamento de Estados Unidos dimi...
WIONFDA Commissioner Marty Makary resigns after clashes over vac...
CBS NewsMarty Makary resigns as FDA commissioner after internal tens...
Le Figaro.frÉtats-Unis : le chef de l'Agence du médicament, Marty Makary...
La RazónEl director de la Agencia del Medicamento de EE UU renuncia ...
El EconomistaTrump anuncia la salida del jefe de la FDA tras más de un añ...
GizmodoThe Mess at the FDA Just Got Bigger as Chief Marty Makary Re...
Bloomberg BusinessMakary's Exit From FDA Gives Biotech Hope the 'Circus' Is Ov...
Le Journal de MontrealLe chef de la FDA "va s'en aller", dit Trump
TVA NouvellesLe chef de l'Agence américaine du médicament " va s'en aller...
About these frames
The Architect: Stability, law, enforcement, institutional design, separation of powers, regulatory process, rule of law. How are order and governance maintained?
The Advocate: Liberty, speech, privacy, autonomy, rights, consent, choice. What freedoms are at stake.
The Watchdog: Wrongdoing, responsibility, corruption, transparency. Who knew what, when, and what they did about it.
The First Responder: Who gets hurt or helped. Quality of life, vulnerable groups, public health, human cost and benefit.
The Analyst: Costs, jobs, inflation, growth, incentives, markets, tradeoffs. Follow the money.
The Guardian: Sanctity, degradation, bodily autonomy, moral boundaries, human dignity, bioethics, environmental purity. Where are the lines that should not be crossed?
See this differently than someone you know would? Two ways to keep it going.
The dial works on any URL — paste an article you read elsewhere this week.